Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.850
+0.110 (4.01%)
At close: Jun 26, 2026, 4:00 PM EDT
2.840
-0.010 (-0.35%)
After-hours: Jun 26, 2026, 7:25 PM EDT
Editas Medicine Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Editas Medicine stock have an average target of 6.37, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 123.51% from the current stock price of 2.85.
Analyst Consensus: Buy
* Price targets were last updated on May 27, 2026.
Analyst Ratings
The average analyst rating for Editas Medicine stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 6 | 6 | 5 | 5 | 4 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 14 | 14 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI | Evercore ISI | Buy Maintains $15 | Buy | Maintains | $15 | +426.32% | May 27, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +75.44% | May 26, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $13 → $8 | Buy | Maintains | $13 → $8 | +180.70% | May 14, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 7, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $4 | Hold | Maintains | $4 | +40.35% | May 6, 2026 |
Financial Forecast
Revenue This Year
14.35M
from 40.52M
Decreased by -64.58%
Revenue Next Year
14.68M
from 14.35M
Increased by 2.30%
EPS This Year
-1.00
from -1.80
EPS Next Year
-0.94
from -1.00
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 32.4M | 32.4M | |
| Avg | 14.4M | 14.7M | |
| Low | 5.8M | 2.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -20.0% | 125.9% | |
| Avg | -64.6% | 2.3% | |
| Low | -85.6% | -86.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -1.00 | -0.94 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.